NPC
ATRS

National Planning Corporation’s Antares Pharma, Inc. ATRS Stock Holding History

National Planning Corporation’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,900
Closed -$42K – 665
2017
Q3 		$42K Sell
12,900
-45,333
-78% -$140K ﹤0.01% 676
2017
Q2 		$186K Buy
58,233
+6,000
+11% +$17K 0.01% 689
2017
Q1 		$153K Hold
52,233
– – 0.01% 664
2016
Q4 		$115K Sell
52,233
-5,000
-9% -$9.52K 0.01% 667
2016
Q3 		$93K Sell
57,233
-7,100
-11% -$8.7K 0.01% 633
2016
Q2 		$69K Buy
64,333
+100
+0.2% +$97 0.01% 652
2016
Q1 		$61K Sell
64,233
-667
-1% -$645 0.01% 629
2015
Q4 		$70K Sell
64,900
-15,800
-20% -$22K 0.01% 705
2015
Q3 		$114K Sell
80,700
-18,000
-18% -$35.3K 0.01% 596
2015
Q2 		$196K Sell
98,700
-9,000
-8% -$21.8K 0.02% 586
2015
Q1 		$248K Sell
107,700
-4,000
-4% -$10.1K 0.02% 535
2014
Q4 		$303K Sell
111,700
-500
-0.4% -$1.12K 0.02% 540
2014
Q3 		$227K Sell
112,200
-13,700
-11% -$29.9K 0.02% 632
2014
Q2 		$336K Sell
125,900
-14,950
-11% -$45K 0.03% 534
2014
Q1 		$514K Sell
140,850
-2,500
-2% -$11.1K 0.04% 367
2013
Q4 		$639K Buy
143,350
+2,500
+2% +$10.2K 0.06% 312
2013
Q3 		$614K Buy
140,850
+19,400
+16% +$84.7K 0.06% 306
2013
Q2 		$499K Buy
+121,450
New +$469K 0.06% 280

Other funds holding ATRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

National Planning Corporation's ATRS Position: Q4 2017 in Review

National Planning Corporation sold out of Antares Pharma, Inc. (ATRS) in Q4 2017, closing a stake of 12,900 shares — an estimated $42K sold.

National Planning Corporation first reported a position in ATRS in Q2 2013 and held it in 18 quarters. The position peaked at $639K in Q4 2013. 110 funds tracked by Wall St. Rank hold ATRS as of Q4 2017.

  • National Planning Corporation reported no remaining Antares Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 12,900 Antares Pharma, Inc. shares in Q4 2017, an estimated $42K.
  • National Planning Corporation first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 18 quarters.
  • National Planning Corporation's Antares Pharma, Inc. position peaked at $639K in Q4 2013.
  • 110 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.